Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why?
The clinical activity of the antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP) is thought to be related to its ability to form bifunctional lesions in DNA. trans-Diamminedichloroplatinum(II) (trans-DDP), the stereoisomer of cis-DDP, is clinically ineffective, although it forms bifunctional cross-links in the in vitro reaction with DNA1–4. A question still unsolved is why only cis-DDP is an antitumor drug.
KeywordsCentral Sequence Linkage Isomerization Dinuclear Platinum Metal Coordination Compound Monofunctional Adduct
Unable to display preview. Download preview PDF.
- 2.S. L. Bruhn, J. H. Toney, and S. J. Lippard, Biological processing of DNA modified by platinum compounds, in “Progress in Inorganic Chemistry: Bioinorganic Chemistry”, S. J. Lippard, ed., Wiley, New York (1990).Google Scholar
- 4.M. Sip and M. Leng, DNA, cis-platinum and intercalators: catalytic activity of the DNA double helix, in “Nucleic Acids and Molecular Biology” (vol. 7), F. Eckstein and D. M. J. Lilley, eds., Springer, Berlin (1993).Google Scholar
- 17.R. Rahmouni, A. Schwartz, and M. Leng, Importance of DNA sequence in the reaction of d(ApG) and d(GpA) with cis-diamminedichloroplatinum(II), in “Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy”, S. B. Howell, ed., Plenum Press, New-York (1988).Google Scholar
- 18.N. J. Rampino and V. A. Bohr, Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus comprising the divergent upstream gene and dihydrofolate reductase gene during early G1 phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polymerase, Proc. Nail. Acad. Sci. U.S.A., 91: 10977 (1994).CrossRefGoogle Scholar
- 21.R. Dalbiès, M. Boudvillain, and M. Leng, Linkage isomerization reaction of intrastrand cross-links in trans-diamminedichloroplatinum(II)-modified single-stranded oligonucleotides, Nucleic Acids Res. (in press).Google Scholar
- 22.M. Boudvillain, R. Dalbiès, and M. Leng, Rearrangement of the 1,3-intrastrand crosslinks into interstrand cross-links in transplatinum-modified DNA (submitted for publication).Google Scholar
- 24.U. Belluco, Substitution reactions, in “Organometallic and coordination Chemistry of Platinum”, Academic Press, London (1974).Google Scholar
- 26.F. Gaucheron, J. M. Malinge, A. J. Blacker, J. M. Lehn, and M. Leng, Possible Catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium, Proc. Natl. Acad Sci. U.S.A., 88: 3516 (1991).CrossRefPubMedGoogle Scholar
- 27.D. Payet and M. Leng, DNA, cisplatinum and heterocyclic amines: catalytic activity of the DNA double helix, in “Structural Biology: The State of the Art”, R. H. Sarma and M. H. Sarma, eds, Adenine, Guilderland, NY (1994).Google Scholar